Along with the increased prevalence of obesity, the incidence of vitamin D deficiency is rising with 10-60 % of adults having values lower than 20 ng/ml. 1,2 Serum or plasma 25-hydroxyvitamin D (25OHD) is the most widely accepted measure of vitamin D status (deficiency <20 ng/ml, insufficiency 20-29 ng/ml, and sufficiency >30 ng/ml). Many studies have
Caan et al. 11 measured changes in weight annually for an average of 7 years in 36,282 postmenopausal women in the Women's Health Initiative clinical trial. Women who received daily vitamin D and calcium supplementation had minimal but consistent significant differences in weight compared with those taking placebo (-0.13 kg). 11 These outcomes were observed primarily in women who reported inadequate calcium intakes (<1,200 mg) or vitamin D intakes (<400 IU), with mean differences between treatment groups of -0.19 kg and -0.16 kg, respectively. 25OHD levels were only measured in 1 % of the study population 2 years after randomization and those on supplements were 28 % higher compared with those on placebo. 11 This modest difference could be explained by poor compliance with the supplementation, with the proportion consuming 80 % or more ranging 56-62 % and personal use of supplementation was allowed (up to 1,000 mg calcium and 600-1,000 IU vitamin D), which was equal or greater than the doses being investigated and may have masked any results.
In a similar study, Zhou et al. 12 followed postmenopausal women randomized to vitamin D and calcium, calcium only, or placebo supplementation to look at the effect of supplementation on fractures. After 4 years, weight decreased in the vitamin D and calcium group, was unchanged in calcium group, and increased in placebo (values not reported). 12 When looking at body composition, there was a gain in trunk fat mass and a loss of trunk lean mass, and this was greatest in the placebo group and similar in both supplemented groups. 12 This suggested vitamin D had no added benefit; however, the changes in 25OHD levels were related to changes in body mass index (BMI) and trunk fat mass (r=-0.15; p<0.01), and only those taking vitamin D and calcium supplementation had significant increases in 25OHD levels (~40 % increase) while the others remained stable. 12 There have also been vitamin D supplementation studies that have reported no changes in weight. [13] [14] [15] [16] [17] All studies had significant increases in 25OHD levels following supplementation and found no changes in weight and other measures of body composition in a range of populations. [13] [14] [15] [16] Similarly, Salehpour et al. 17 found no differences in weight and waist circumference, but they did find a greater decrease in fat mass in those treated with vitamin D compared with placebo, and this modest reduction in fat mass was inversely correlated with the increase in 25OHD levels (r=-0.32; p=0.005). 
Increases in Vitamin D Through Fortified Foods and Seasons
Studies have also looked at increasing vitamin D levels through other means, including fortified foods (see Table 3 ) and seasonal changes.
Ortega and colleagues compared two hypocaloric diets: one increased cereals (enriched with vitamin D); the other increased vegetable intake for 2 weeks. Those on the cereal diet significantly increased their vitamin D intake and 25OHD levels compared with no changes in the vegetable diet. 23 While both diets lost weight and fat, those on the cereal diet had greater reductions, suggesting that greater increases in 25OHD resulted in greater losses of body fat and weight. 23, 24 However, there was also a greater reduction in energy intake in cereal diet that was due to a ~1,000 kJ greater initial intake, which may also have contributed to the greater weight loss. 23 While vitamin D intake was increased, it was still suboptimal and the differences were seen over a short time-frame of only 26, 27 One study found no differences in weight changes between the groups, 26 and the other found weight significantly increased by 1.0 kg in the milk group compared with the nonmilk group and there was a trend for a greater increase in fat mass of 0.6 kg. 27 The milk group in the second study also significantly increased their energy compared with no change in the other groups (+846 kJ/day), which could have impacted on the weight gain. Another study with fortified low-fat dairy products found no differences in weight change after 12 months of three dairy servings in combination with a dietary and lifestyle intervention compared with calcium supplementation and a control group. 28 However, researchers did find combining lifestyle counseling with fortified dairy products had favourable changes in some different anthropometric and body composition indices (lower decrease in mid-arm muscle circumference, lower increase in sum of skin fold thickness, greater decrease in percentage of leg fat mass, and greater increase in percent of leg lean mass). 28 25OHD levels were not measured, so they were not able to determine if the fortified products improved vitamin D status or if it was other parts of the intervention that were having the beneficial impact. In the majority of these studies the participants were vitamin D sufficient at baseline [25] [26] [27] that, along with the low dose of vitamin D in the fortified products, could also have accounted for a modest increase in 25OHD levels. In some studies the products led to differences in energy intake that could have influenced subsequent weight loss and the products fortified with vitamin D and calcium. The dairy studies did not include a nonfortified dairy group, which again makes it difficult to distinguish between vitamin D and calcium, and also the impact of dairy, which may also affect adiposity. (summer to winter cohort -13.5 versus -8.4 cm, respectively). 30 The increase US ENDOCRINOLOGY in 25OHD was associated with a greater reduction in waist circumference (r=-0.48; p<0.001). 30 Dawson-Hughes et al. 31 found the reduction in 25OHD levels due to seasonal change was attenuated by vitamin D supplementation (400 IU) in 249 healthy postmenopausal women, but found similar changes in weight, fat mass, and lean mass during these times when comparing vitamin D and placebo. While BMI was not reported, the average weight of the participants was approximately 68 kg and suggests they were not overweight so perhaps less likely to lose weight.
Do 25-Hydroxyvitamin D Levels Change with Weight Loss?
Many studies have reported lower 25OHD levels in overweight and obese populations, so it is possible they may increase with weight loss, in particular through the loss of adipose tissue, which would increase its bioavailability. Several weight loss/diet interventions have measured vitamin D before and after weight loss (see Table 4 ). Recently, Wamberg et al. 32 observed a 27 % increase in 25OHD levels after 11 % weight loss and found the relative change in 25OHD levels correlated with relative weight loss. Another study found a similar increase in 25OHD levels (31 %) following 16 weeks of dietary support (14 % weight and 24 % fat mass loss) and there was a strong correlation between change in 25OHD levels and weight loss and a smaller but still significant correlation with fat mass changes. 33 Both of these studies provided diet formula products to assist with weight loss that were enriched with vitamin D, but as they contained less than 8 μg/day, they were not likely to increase 25OHD levels to the extent seen in the studies. This suggests, along with the relationship between weight loss and changes in 25OHD, that the increases in 25OHD may be due to the weight loss.
A longitudinal study in obese women following 11.5 % weight loss found a 10 % increase in 25OHD levels. 34 While this increase in 25OHD levels was significant, it was small and likely not clinically significant and 25OHD levels remained below those of normal weight women (40.1±18.6 ng/ml). Tzotzas et al. 35 also observed a similar weight loss (10 % weight and percent fat mass loss and 9 % reduction in waist circumference) but saw a greater increase in 25OHD levels (34 %); however, the magnitude was the same (2.9 ng/ml). 35 These participants were deficient at baseline and 25OHD levels were much lower and almost half of the previous study (15.4 ng/ml). There was a trend for a relationship between weight loss and change in 25OHD.
However when assessed at 4 weeks when there was small but significant 4 % weight loss, there was no change in 25OHD. The diet contained an average 221 IU per day, which is below the recommended adequate intake, suggesting it did not lead to the increase in 25OHD. These results suggest that there might be a threshold of weight loss or time needed to see a significant increase in 25OHD levels.
By contrast, another study showed the opposite picture: Riedt and colleagues 36 found no change in 25OHD levels following 7.2 % weight loss in premenopausal women. However in a subset of participants analyzed at week 6, there was a significant 27 % increase in 25OHD levels. It is likely that seasonal changes affected these findings, with the participants that were recruited in early fall having higher baseline values and smaller changes over 6 months compared with those recruited in late winter (baseline 32.9±8.2 versus 29.4±8.9 ng/ml; changes 1.1±17.9 % versus 19.8±18.2 %; respectively). 36 There have also been studies that did not see any changes in 25OHD after weight loss. Hinton et al. 37 found no changes in 25OHD levels post-12 weeks of weight loss and, interestingly, it decreased significantly following 24 weeks of weight maintenance. The researchers found a significant season by time interaction, indicating that the change in 25OHD levels was dependent on season during enrolment and suggested seasonal variation may have had a greater impact on 25OHD than changes in weight or fat mass. 37 Mason et al. 38 investigated overweight and obese postmenopausal women undergoing three different lifestyle modification programs and a control group and found no significant changes in 25OHD levels after 12 months compared with control participants, despite significant weight loss. Interestingly, the use of personal vitamin D supplementation decreased over the 12 months, with the proportion of participants taking supplements decreasing from ~50 % to 39 %; however, the daily intake among users increased (530 IU/day to 787 IU/day) and this could have influenced the study outcomes. 38 However, what the study did find was a dose-dependent increase in 25OHD levels associated with the magnitude of weight loss, with greater weight loss having greater increase in 25OHD levels (<5 %, 2.1 ng/ml; 5-9.9 %, 2.7 ng/ml; 10-14.9 %, 3.3 ng/ml; ≥15 %, 7.7 ng/ml), and only those that lost more than 15% weight significantly increased 25OHD levels greater than control participants. 38 Changes in 25OHD levels were also associated with reductions in BMI and fat mass. 38 Rock et al. 39 found a similar pattern with weight-change categories after a 2-year weight-loss intervention. Again, while they did not report an overall change in 25OHD levels for the entire study, they did find changes in 25OHD levels were mildly inversely correlated with changes in weight, and there was a significant linear trend between the change in 25OHD levels and weight change categories, such that those with greater weight loss had greater increases in 25OHD levels. During the study vitamin D supplement use increased from 20 % to 50 %; however, vitamin D use did not differ across the weight change categories, suggesting it was not supplement use that lead to greater increases in 25OHD in the weight-loss groups.
As mentioned above, some studies have also investigated the relationship between the changes in 25OHD levels and measures of body composition.
The strength of these relationships ranges from 0.16 to 0.67, suggesting weak to strong relationships. Other studies, although not weight-loss studies, also found weak relationships between changes in fat mass and 25OHD levels. 12, 17 It appears that most studies either observed an increase in 25OHD levels, a pattern where there were greater increases in those that lost more weight or a relationship between the degree of weight loss and increases in 25OHD levels. It may be possible that a threshold of weight loss is needed to see an increase in 25OHD levels. Many of these studies
were not primarily designed to measure the effect of weight loss on 25OHD levels so did not take season or prior use or changes in vitamin D supplementation into consideration in the study design, which may have greatly influenced some of the findings.
Do Baseline 25-Hydroxyvitamin D Levels Predict Subsequent Weight Loss?
It has been suggested that participants with better vitamin D status at the start of a weight-loss program may be more likely to experience successful weight loss. A study in 60 women found that those with baseline 25OHD levels 20 ng/ml or more lost more fat after 2 weeks of energy restriction compared with those with 25OHD levels less than 20 ng/ml (average 25OHD levels 31.9±15.5 versus 15.0±3.2 ng/ml; average fat loss -1.7±1.8 versus -0.5±0.8 kg, respectively). 24 When split into groups 30 ng/ml or greater and 10 ng/ml or less, again, even greater fat loss was seen in those with higher 25OHD levels (-2.9±2.2 versus -0.4±0.7 kg) and also greater weight loss (-1.6±0.8 versus -0.8±0.7 kg). 23 There was no difference in the reduction in energy intake between these groups, suggesting the baseline vitamin D status may be affecting the results, especially in those with sufficient levels. Although the sample size was small and the intervention was short, the resultant weight and fat loss was significantly greater in the group with higher 25OHD levels and suggests that those with better vitamin D status respond more positively to energy restriction and lose more fat and this could lead to even greater improvements seen over a longer time.
Shahar and colleagues 40 followed 322 men and women undergoing weight loss via three different diets and found that baseline 25OHD levels were not associated with weight loss after 2 years. However they did find that higher 25OHD levels assessed at 6 months in a representative sample (n=126) were associated with greater weight loss after 2 years (tertiles of 25OHD: 14.5, 21.2, and 30.2 ng/ml; weight loss: -3.1±5.7, -3.8±4.4, and -5.6±6.6 kg). 40 Interesting between-baseline and 6-months 25OHD levels decreased due to seasonal changes from summer to winter and when split into tertiles of change, those in the highest tertile which on average increased (median values, -9.2, -2.6 and 2.5 ng/ml) experienced greatest US ENDOCRINOLOGY weight loss at 24 months (-2.5±4.9, -4.0±5.3, and -5.8±7.0 kg) and 6 months (statistics not reported, approximate values from graph, -3.5, -4, and -8 kg). 40 25OHD values were not measured at the end of the study so unable to determine if they changed with weight loss over 24 months.
There were two other weight-loss studies that also showed no relationship between baseline 25OHD levels and subsequent weight loss. 25, 38 Baseline 25OHD levels were not associated with changes in BMI, subcutaneous adipose tissue, and visceral adipose tissue after 16 weeks 25 and with greater weight loss, reductions in fat, or preservation of lean tissue after 12 months. 38 However in one study the weight loss was minimal at 2.5 kg (~3 %) and the other stated the range of 25OHD levels were low overall and the range of concentrations may have been inadequate to detect an effect. 38 Another study by Sneve et al. 15 again found no differences in weight changes when dividing the cohort according to baseline 25OHD levels, but this was not a weight-loss study and there were no changes in weight overall during the study.
Conclusions
To date there has been inconsistent findings when looking at the effects of 
